Evidence map›Paper›PMID 39680546›Full record

ArticlePloS one2024

Associations between dietary mycotoxins exposures and risk of hepatocellular carcinoma in a European cohort.

Inge Huybrechts, Inarie Jacobs, Carine Biessy, Elom K Aglago, Mazda Jenab, Liesel Claeys, Jiri Zavadil, Corinne Casagrande, Genevieve Nicolas, Ghislaine Scelo and 31 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Oral Exposure toToxins · 2025
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Inge HuybrechtsInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.
Inarie JacobsInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.ORCID 0000-0002-5989-5414
Carine BiessyInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.
Elom K AglagoInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.ORCID 0000-0002-0442-3284
Mazda JenabInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.ORCID 0000-0002-0573-1852
Liesel ClaeysCRIG, Cancer Research Institute Ghent, Ghent, Belgium.
Jiri ZavadilInternational Agency for Research on Cancer (IARC/WHO), Epigenomics and Mechanisms Branch, Lyon, France.ORCID 0000-0003-0640-5562
Corinne CasagrandeInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.
Genevieve NicolasInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.ORCID 0000-0001-7871-7149
Ghislaine SceloInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.
Andrea AltieriEuropean Food Safety Authority (EFSA), Parma, Italy.
Beatrice FerversCentre Léon Bérard, Lyon, France.
Isabelle P OswaldToxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.
Julien VignardToxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France.ORCID 0000-0001-6379-1741
Bernadette ChimeraInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.ORCID 0000-0002-7238-1469
Maria Santucci de MagistrisAzienda Ospedaliera Universitaria (AOU) Federico II, Naples, Italy.
Giovanna MasalaInstitute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Domenico PalliInstitute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Lisa PadroniUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.ORCID 0009-0008-9609-3681
Jesús CastillaInstituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.ORCID 0000-0002-6396-7265
Ana Jiménez-ZabalaCIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Pauline FrenoyUVSQ, Inserm "Exposome, Heredity, Cancer and Health" Team, CESP U1018, Gustave Roussy, Université Paris-Saclay, Villejuif, France.ORCID 0000-0002-7435-5125
Francesca Romana ManciniUVSQ, Inserm "Exposome, Heredity, Cancer and Health" Team, CESP U1018, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Xuan RenUVSQ, Inserm "Exposome, Heredity, Cancer and Health" Team, CESP U1018, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Emily SonestedtDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Paolo VineisCancer Epidemiology and Prevention Research Unit, School of Public Health, Imperial College London, London, United Kingdom.
Alicia HeathCancer Epidemiology and Prevention Research Unit, School of Public Health, Imperial College London, London, United Kingdom.ORCID 0000-0001-6517-1300
Mårten WernerDepartment of Public Health and Clinikal Medicine, Umeå University, Umeå, Sweden.
Esther Molina-MontesCIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Christina C DahmDept. of Public Health, Aarhus University, Aarhus, Denmark.
Fie LangmannDept. of Public Health, Aarhus University, Aarhus, Denmark.ORCID 0000-0003-3474-9346
José María HuertaCIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.ORCID 0000-0002-9637-3869
Magritt BrustadDepartment of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Guri SkeieDepartment of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Antonio AgudoUnit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, L'Hospitalet de Llobregat, Spain.
Sabina SieriEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Michael KorenjakInternational Agency for Research on Cancer (IARC/WHO), Epigenomics and Mechanisms Branch, Lyon, France.
Marc J GunterInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.
Sarah De SaegerCRIG, Cancer Research Institute Ghent, Ghent, Belgium.ORCID 0000-0002-2160-7253
Marthe De BoevreCRIG, Cancer Research Institute Ghent, Ghent, Belgium.ORCID 0000-0002-6151-5126

Funding

World Health Organization 001
6 · The paper itself

Abstract

Mycotoxins have been hypothesized to contribute to a diversity of adverse health effects in humans, even at low concentrations. Certain mycotoxins are established human carcinogens, whereas for others research suggests potential carcinogenic effects. The aim of this study was to determine the association between dietary exposure to mycotoxins and hepatobiliary cancers in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. EPIC questionnaire data were matched to mycotoxin food occurrence data compiled by the European Food Safety Authority to assess long-term dietary mycotoxin exposure (expressed as μg/kg body weight/day) and then relate them to the risk of hepatocellular carcinoma (HCC) (n = 255) and biliary tract cancers (n = 273). Analyses were conducted using multivariable Cox proportional hazards regression models to compute hazard ratios (HR) and 95% confidence intervals (95% CI). Key food groups contributing to mycotoxin exposure were cereals and cereal-based products, vegetables, non-alcoholic beverages (including fruit juices) and fruits. Estimated intake of deoxynivalenol (DON) and its derivatives was positively associated with HCC risk (HRT3vsT1: 1.90, 95% CI: 1.18-3.05, p-trend <0.01). No statistically significant associations were found for the other mycotoxins. Further research to confirm our observations and investigate potential underlying mechanisms of these compounds is warranted. These data may provide evidence of HCC risks associated with higher dietary intake levels of DON, which has not yet been classified as a human carcinogen.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsMycotoxinsAdultAgedCohort StudiesDietDietary ExposureEuropeFemaleFood ContaminationHumansMaleMiddle AgedProportional Hazards ModelsProspective StudiesMycotoxinsTrichothecenes

Identifiers

PMID39680546
PMCPMC11649147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.